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ABSTRACT: A convenient and scalable synthesis of 1,2-dihydropyridazines is presented, based on 
the Diels-Alder cycloaddition of 1-acetoxy-1,3-butadiene with a variety of azo compounds, 
followed by a palladium-catalyzed elimination. The products are produced on gram-scale and the 
new method is particularly efficient and atom-economical when compared with previously 
published preparations of 1,2-dihydropyridazines. 
 
For ongoing projects, we required ready access to multigram quantities of 1,2-dihydropyridazines 
2, which have only rarely been described in the literature.1-6 We felt that 1,2-dihydropyridazines 
represent potentially interesting molecular building blocks, envisioning selective double-bond 
functionalisations, diene-type reactivity and N-N bond cleavage providing access to a wide variety 
of different molecular scaffolds. Indeed, preliminary studies have shown that simple 1,2-
dihydropyridazines undergo electrocyclic reactions,1a,2-4,7 (producing bicyclic diazetidines, 2-
aminopyrroles and conjugated imines) as well as Diels-Alder reaction with 4-phenyl-1,2,4-
triazole-3,5-dione (PTAD),5,8 whilst more substituted 1,2-dihydropyridazines have been used as 
precursors to substituted pyridazine derivatives.9 In addition, unusual photochemical reactions 
of selected 1,2-dihydropyridazines have also been reported.10 
 
To enable a more comprehensive study of the synthetic potential of 1,2-dihydropyridazines 2, 
we required an efficient synthesis suitable for multigram scale. Initially, we assessed previously 
described routes to 1,2-dihydropyridazines 2, starting with an approach first reported by Altman 
and co-workers,1 (and later employed by other authors),2-4 which involves the Diels-Alder 
cycloaddition of 1,3-butadiene with dimethyl azodicarboxylate to give tetrahydropyridazine 1, 
followed by allylic bromination then dehydrobromination to generate 2 (Scheme 1). Whilst the 
initial Diels-Alder cycloaddition proceeded as expected with a range of azodicarboxylate 
reagents, the requirement for carbon tetrachloride (a toxic and ozone-depleting chemical) in the 
allylic bromination step is a major disadvantage. Unfortunately, our attempts to identify more 
sustainable reaction conditions for the allylic bromination were unsuccessful, thus we turned our 
attention to a related synthetic approach,5,6 in which tetrahydropyridazine 1 is converted into 
dihydropyridazine 2 via a bromination/double dehydrobromination sequence (Scheme 1). 
However, the process proved capricious, and only poor yields of impure dihydropyridazines could 
be obtained after the bromination/elimination sequence. Hence, as the existing synthetic routes 
to 2 were unsuitable for larger-scale work, we sought to develop a new scalable synthetic 
approach to 1,2-dihydropyridazines 2 by incorporating a suitable leaving group (LG) into the 
diene 3, thereby allowing elimination directly from the resulting cycloadduct 4 and negating the 
need for bromination procedures. 
 





Scheme 1 Footnote: PG = protecting group, LG = leaving group, NBS = N-bromosuccinimide, DMF 
= dimethylformamide. 
 
At the outset, the Diels-Alder cycloadditions of diisopropyl azodicarboxylate (DIAD) with a range 
of substituted dienes 3 (LG = OAc, OBz, OPiv or OCO2Et) were studied, generating 
tetrahydropyridazine intermediates 4. Of the dienes tested, 1-acetoxy-1,3-butadiene (3a; LG = 
OAc) gave the most promising results in terms of the stability and the isolated yield of the 
resulting cycloadduct 5c, which was sufficiently stable to purification by flash column 
chromatography (although some degradation during purification was observed, pure samples of 
5c were readily obtained). Next, attention turned to the elimination of intermediate 5c to give 
1,2-dihydropyridazine 2c. Initially, the elimination was attempted under a range of mild acidic or 
basic conditions, but in these cases the starting material was recovered unchanged. When more 
forcing acidic or basic conditions were employed, no 1,2-dihydropyridazine product 2c was 
obtained, but significant decomposition of the starting material took place. Therefore, we 
wondered whether the desired transformation could be carried out using palladium catalysis. 
Whilst the palladium-catalyzed elimination of allylic acetates is well known,11 to our knowledge 
there is no precedent for palladium-catalyzed elimination in heterocyclic systems such as 5. 
Pleasingly, the application of a variety of palladium catalysts resulted in conversion of 5c into 2c, 
although in some cases, rearrangement of the starting material (to produce allylic acetate 6c) was 
observed in addition to the desired elimination process (Table 1). Interestingly, the palladium-
catalyzed elimination of allylic acetate 6c to 2c was extremely sluggish, therefore it was crucial to 
suppress the formation of 6c to allow efficient conversion of 5c to 2c.  
 
Table 1. Optimisation of the Palladium-Catalyzed Elimination of Allylic Acetate 5c 
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Table 1 footnote: aIsolated yield of product (column chromatography) bDifficulties encountered 
in separating 2c from dibenzylideneacetone cReaction time of 2 hours 
 
Several different palladium catalysts were tested, with Pd(OAc)2 proving optimal, although the 
choice of ligand had a strong effect on the selectivity for 2c over 6c. Thus, whilst the use of dppp 
gave approximately equal amounts of 2c and 6c, Xantphos and triphenylphosphine led selectively 
to 2c in good yields. However, using Xantphos, reducing the catalyst loading from 10 mol% to 1 
mol% switched the selectivity to give 6c as the major product (compare entries 5 and 6). In 
contrast, no such loss in selectivity was observed when Pd(OAc)2/triphenylphosphine was 
employed at low catalyst loading, and the desired product 2c could be selectively obtained in 
excellent yield using only 1 mol% Pd(OAc)2 (entry 7). In this case, the inclusion of two equivalents 
of triethylamine led to more reproducible results. After further optimisation of the elimination 
conditions (see the Supporting Information), Pd(OAc)2, triphenylphosphine, triethylamine and 
1,4-dioxane emerged as the optimal catalyst, ligand, base and solvent respectively. 
 
Having identified optimised conditions for the elimination, the two-step cycloaddition-
elimination sequence was next applied to a range of different azo compounds. Thus, in addition 
to DIAD, diene 3a also underwent successful cycloaddition with five other symmetrical 
azodicarboxylate reagents to generate the corresponding acetoxytetrahydropyridazines 5, each 
bearing different carbamate protecting groups (Scheme 2). Moreover, two non-symmetrical 
azodicarboxylate reagents were also investigated, yielding tetrahydropyridazine products 5f and 
5g, each bearing two orthogonal protecting groups. The acetoxytetrahydropyridazine 
intermediates 5 required only a rapid purification through a short plug of silica (to remove excess 
diene 3a) before being subjected to elimination to give the desired 1,2-dihydropyridazines 2 
(Scheme 2).  
 




Footnote for Scheme 2: aReaction conditions: 3a (1.5 equiv.), azo compound (1.0 equiv.; 4.0-7.0 
mmol), CH2Cl2 (2.5-5.0 M), rt or 40 °C, 1-40 h, then Pd(OAc)2 (1 mol%), PPh3 (4 mol%), NEt3 (2.0 
equiv), 1,4-dioxane (0.5 M), reflux, 1 h; bIsolated yields over two steps after column 
chromatography; cAs footnote a, but yield calculated over three steps also including synthesis of 
the azo compound from the corresponding hydrazine; dAs footnote a, but the elimination was 
carried out using 2 mol% Pd(OAc)2 and 8 mol% PPh3. 
 
The elimination procedure was applied to the eight different cycloadducts 5, allowing the 
preparation of the corresponding 1,2-dihydropyridazines 2 on gram-scale in generally high yields 
(Scheme 2). Product yields are calculated over two steps (the Diels-Alder cycloaddition and the 
subsequent elimination), when using commercially available azodicarboxylate reagents (i.e. for 
2b, 2c, 2d and 2e), whereas for 1,2-dihydropyridazines 2a, 2f, 2g and 2h, the yields are calculated 
over three steps, including the preparation of the azodicarboxylate reagent from the 
corresponding hydrazine. In the case of 2f and 2g, lower yields were obtained than those for the 
other 1,2-dihydropyridazines, due to the competing formation of rearrangement products 6f and 
6g respectively. Doubling the catalyst loading resulted in improved yields of 2f/2g compared with 
those obtained under the standard conditions (46% yield compared with 22% yield for 2f; 55% 
yield compared with 43% yield for 2g), but in these cases the rearrangement pathway could not 
be completely suppressed. It should also be noted that in general, the presence of water tends 
to promote the formation of rearrangement products 6, therefore the cycloadducts 5 were 
generally dried in a vacuum dessicator prior to the elimination step. Overall, the two-step reaction 
sequence is easy to perform and is scalable, as demonstrated by the four-fold scale-up of the 
synthesis of 1,2-dihydropyridazine 2d, which produced four grams of 2d in comparable yield to 
that obtained on gram-scale. 
 
The 1H and 13C NMR spectra of 1,2-dihydropyridazines 2a-g are complex, and deserve some 
comment. At room temperature, broad signals are generally observed, and at least two species 
are apparent that are in the immediate exchange regime on the NMR timescale. At 75 °C, (partial) 
coalescence of the peaks occurs, thus simplifying the spectra considerably (see the Supporting 
Information for variable-temperature NMR studies on 1,2-dihydropyridazine 2b), whilst upon 
heating over 100 °C, degradation occurs. These observations mirror those of Anderson and Lehn, 
who reported that diethyl 3,6-diphenyl-1,2-pyridazinedicarboxylate is non-planar in solution, 
based on 1H NMR spectroscopic data that indicated a non-symmetrical structure.12 In this case, 
the authors suggested the presence of slowly equilibrating “twisted” conformations  similar to 
those reported for 1,3-cyclohexadiene.13 In contrast, Fisher and co-workers studied the same 
dihydropyridazine by 13C NMR spectroscopy, and concluded that a symmetrical species was 
present, as only one set of resonances was observed.14 Finally, Kaftory and co-workers concluded 
from their crystallographic study that the twist-boat conformation observed in the solid state is 
likely also predominant in solution.15 To our knowledge, no spectral data have been reported for 
other 1,2-dihydropyridazines, but our 1H and 13C NMR data (for 2a-g) are consistent with a 
dynamic ring-twisting process in line with that described by Anderson and Lehn, and NMR data 
for 2a-2g are provided at both ambient and elevated temperatures. Analysis of a single crystal of 
2c confirmed a twisted conformation in the solid state (Figure 1), which is similar to that reported 
by Kaftory and co-workers, and apparent in the solid-state structure of 2c due to the large C-N-N-
C torsion angle of 44.74(11)° as well as the C=C-C=C torsion of 17.87(14)°. 
 
 
Figure 1. Solid-state molecular structure of 2c with thermal ellipsoids drawn at 50% probability. 
 
In contrast, dihydropyridazine 2h does not exhibit this ring-twisting behaviour (a single set of 
resonances is observed by 1H and 13C NMR spectroscopy), presumably due to the lack of 
conformational freedom afforded by its fused bicyclic structure. It should be noted that several 
detailed spectroscopic analyses on tetrahydropyridazines have been reported,16 which display 
similar dynamic behavior to dihydropyridazines 2a-g. 
In summary, we have developed a new method for the preparation of 1,2-dihydropyridazines 
based on a novel Diels-Alder/palladium-catalyzed elimination sequence, which is particularly 
efficient and easy to perform when compared with the previously published synthetic routes. The 
two-step sequence is readily scalable, producing multigram quantities of 1,2-dihydropyridazines, 
and this convenient synthetic approach will enable detailed studies into the synthetic potential 
of these interesting heterocycles. Indeed, further work towards this goal is already underway, and 




General Methods and Materials 
 
Reagents were purchased in the highest purity available from Acros Organics, Alfa Aesar and 
Sigma Aldrich. Anhydrous solvents used in reactions were purchased from Acros Organics 
equipped with AcroSealTM and all other solvents used were of reagent grade. Triphenylphosphine 
was recrystallized from hexane prior to use. Brine refers to a saturated aqueous solution of 
sodium chloride, and water is distilled water.  Reaction vessels were oven dried and cooled under 
an argon atmosphere prior to use and experiments were performed under argon gas. Palladium 
reactions were performed in Biotage 5-mL or 20-mL microwave vials and sealed with a cap. 
Reactions were monitored by thin-layer chromatography (TLC) and/or 1H NMR spectroscopic 
analysis.  
Analytical TLC was carried out using Merck pre-coated aluminum-backed TLC silica gel plates 
(silica gel 60 F254) and the plates were visualised by UV light (254 nm) and by staining with either 
potassium permanganate or aqueous acidic ammonium molybdate(IV). Normal phase flash 
column chromatography on silica gel was carried out using silica gel from VWR (40-63 microns).  
1H NMR spectroscopic data were obtained on either 300 or 400 MHz instruments and 13C{1H} 
NMR data were obtained at 100 MHz (Bruker Ultrashield 400 Plus) at 298 K unless otherwise 
specified. The chemical shifts are reported in parts per million (δ) relative to residual CHCl3 (δH = 
7.26 ppm) and CDCl3 (δC = 77.16 ppm, central line), residual d5-DMSO (δH = 2.50 ppm) and d6-
DMSO (δC = 39.52 ppm). The assignment of the signals in the 1H and 13C NMR spectra was 
achieved through 2D-NMR techniques: COSY, HSQC and HMBC. Coupling constants (J) are quoted 
in Hertz. Infrared spectra were recorded on an Agilent Technologies Cary 630 FTIR spectrometer. 
Melting points were performed on a Sanyo Gallenkamp capillary melting point apparatus and are 
uncorrected. High resolution mass spectrometry data were recorded using electron spray 
ionization (ESI) or atmospheric pressure chemical ionization (APCI) on a Shimadzu LCMS-IT-TOF 
mass spectrometer.  
 
General procedure A: Synthesis of hydrazine-1,2-dicarboxylates from carbazates 
Pyridine (3.0-6.0 eq) was added dropwise to a stirred solution of carbazate (1.0 eq.) and the 
desired chloroformate (1.1-1.2 eq.) in 2-MeTHF (0.5 or 1 M) at 0 ˚C under argon. The resulting 
suspension was stirred at 0 ˚C for 15 minutes and then at room temperature for 1.5 hours. A 10% 
(v/v) aqueous solution of HCl (10 mL) was added and the mixture was extracted with CH2Cl2 (5 x 
20 mL). The combined organic layers were washed with brine (10 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. If purification was required, the 
crude product was purified by flash column chromatography using an appropriate solvent 
system, as described for each individual procedure. 
 
General procedure B: Synthesis of 1,2-dihydropyridazines starting from commercially available 
azo compounds 
1-Acetoxy-1,3-butadiene (1.5 eq.) was added in one portion to a solution of the azo compound 
(1.0 eq.) in CH2Cl2 (2.5 or 5 M) and stirred at either room temperature or 40 °C for a specific 
length of time depending on the azo compound. The reaction mixture was evaporated under 
reduced pressure and the crude product was passed through a short silica gel column using an 
appropriate solvent system, as described for each individual procedure, to give the cycloadducts 
that contained minor impurities. The cycloadducts were dried in a desiccator, dissolved in 1,4-
dioxane (0.5 M) and added to an oven-dried microwave vial (under argon) that contained 
Pd(OAc)2 (1.0 mol%), PPh3 (4.0 mol%) and triethylamine (2.0 eq.)  The vial was sealed, then 
heated at reflux for 1 hour. The reaction mixture was cooled to room temperature and 
evaporated under reduced pressure to give the crude product. The crude product was purified 
by flash column chromatography using an appropriate solvent system, as described for each 
individual procedure.  
 
General procedure C: Synthesis of 1,2-dihydropyridazines starting from hydrazine-1,2-
dicarboxylates  
1-Acetoxy-1,3-butadiene (1.5 eq.) was added in one portion to a suspension of hydrazine-1,2-
dicarboxylate (1.0 eq.) and iodobenzene diacetate (1.0 eq.) in CH2Cl2 (0.6, 1.0 or 2.5 M) and 
stirred at either room temperature or 40 °C for a specific length of time depending on the azo 
compound. The reaction mixture was evaporated under reduced pressure and the crude product 
was passed through a short silica gel column using an appropriate using an appropriate solvent 
system, as described for each individual procedure, to give the cycloadducts that contained minor 
impurities. The cycloadduct was dried in a desiccator, dissolved in 1,4-dioxane (0.5 M) and added 
to an oven-dried microwave vial (under argon) that contained Pd(OAc)2 (1.0 mol%), PPh3 (4.0 
mol%) and triethylamine (2.0 eq.)  The vial was sealed, then heated at reflux for 1 hour. The 
reaction mixture was cooled to room temperature and evaporated under reduced pressure to 
give the crude product. The crude product was purified by flash column chromatography using 
an appropriate solvent system, as described for each individual procedure.  
 
Dimethyl-1,2-dihydropyridazine-1,2-dicarboxylate (2a)2 
Using general procedure C, a mixture of hydrazine S1 (1.00 g, 6.74 mmol), iodobenzene diacetate 
(2.20 g, 6.75 mmol) and 1-acetoxy-1,3-butadiene (1.2 mL, 10.1 mmol) in CH2Cl2 (2.7 mL) was 
stirred at room temperature for 17 hours. After being passed through a short silica gel column 
(eluent: hexane-EtOAc, 2:1→1:1), cycloadduct (1.72 g, 6.66 mmol), Pd(OAc)2 (15 mg, 0.07 mmol), 
triphenylphosphine (70 mg, 0.27 mmol) and triethylamine (1.9 mL, 13.3 mmol) in 1,4-dioxane (13 
mL) gave the crude product. Purification by flash column chromatography on silica gel (eluent: 
hexane-EtOAc, 4:1) gave dihydropyridazine 2a (923 mg, 4.66 mmol, 69%) as a yellow oil, which 
solidified to an off-white solid on standing. Rf (Hexane-EtOAc, 2:1) = 0.26; mp = 62-64 ˚C; 1H NMR 
(400 MHz, 298 K, d6-DMSO); δ 6.92-6.66 (br m, 2H, NC=H), 5.92-5.70 (br m, 2H, NCHC=H), 3.74 
(s, 6H, OCH3); 1H NMR (400 MHz, 348 K, d6-DMSO); δ 6.76 (dd, J = 5.2, 2.5 Hz, 2H, NC=H), 5.81 
(dd, J = 5.2, 2.5 Hz, 2H, NCHC=H), 3.76 (s, 6H, OCH3); 13C NMR (100 MHz, 298 K, d6-DMSO, 
additional peaks due to complex rate processes denoted by an asterisk); δ 153.8 (C=O), 127.3 
(NC=H), 113.4* (NCHC=H), 112.1 (NCHC=H), 53.7 (OCH3); 13C NMR (100 MHz, 348 K, d6-DMSO); δ 
153.2 (C=O), 127.0 (NC=H), 112.2 (NCHC=H), 53.2 (OCH3); FTIR (ATR) ν (cm-1): 2958, 1715 (C=O); 
HRMS (APCI): m/z calculated for: C8H10N2O4 [M+H]+ 199.0713, found 199.0719.  
 
Diethyl 1,2-dihydropyridazine-1,2-dicarboxylate (2b)3 
Using general procedure B, diethyl azodicarboxylate (1.0 mL, 6.35 mmol) and 1-acetoxy-1,3-
butadiene (1.1 mL, 9.53 mmol) in CH2Cl2 (1.3 mL) was stirred at room temperature for 9 hours. 
After being passed through a short silica gel column (eluent: hexane-EtOAc, 5:1→2:1), 
cycloadduct (1.85 g, 6.44 mmol), Pd(OAc)2 (14 mg, 0.06 mmol), triphenylphosphine (67 mg, 0.26 
mmol) and triethylamine (1.8 mL, 12.7 mmol) in 1,4-dioxane (13 mL) gave the crude product. 
Purification by flash column chromatography on silica gel (eluent: hexane-EtOAc, 9:1→4:1) gave 
dihydropyridazine 2b (1.29 g, 5.72 mmol, 90%) as a white solid. Rf (hexane-EtOAc, 1:1) = 0.51; mp 
= 56-58 ˚C; 1H NMR (400 MHz, 298 K, d6-DMSO); δ 6.89-6.65 (br m, 2H, NC=H), 5.89-5.72 (br m, 
2H, NCHC=H), 4.24-4.09 (br m, 4H, OCH2), 1.21 (br t, J = 7.0 Hz, 6H, CH2CH3); 1H NMR (400 MHz, 
348 K, d6-DMSO); δ 6.75 (br dd, J = 5.2, 2.5 Hz, 2H, NC=H), 5.79 (br dd, J = 5.2, 2.5 Hz, 2H, NCHC=H), 
4.26-4.14 (m, 4H, OCH2), 1.24 (t, J = 7.1 Hz, 6H, CH2CH3); 13C NMR (100 MHz, 298 K, d6-DMSO, 
additional peaks due to complex rate processes denoted by an asterisk); δ 153.2 (C=O), 127.3 
(NC=H), 113.2* (NCHC=H), 111.9 (NCHC=H), 62.6 (OCH2), 14.2 (CH2CH3); 13C NMR (100 MHz, 348 
K, d6-DMSO); δ 152.6 (C=O), 127.0 (NC=H), 112.0 (NCHC=H), 62.2 (OCH2), 13.8 (CH2CH3); FTIR 
(ATR) ν (cm-1): 3088, 2989, 1754 (C=O), 1715 (C=O); HRMS (ESI): m/z calculated for: C10H14N2O4 
[M+Na]+ 249.0846, found 249.0847. 
 
Diisopropyl 1,2-dihydropyridazine-1,2-dicarboxylate (2c) 
Using general procedure B, diisopropyl azodicarboxylate (1.0 mL, 5.08 mmol) and 1-acetoxy-1,3-
butadiene (0.9 mL, 7.62 mmol) in CH2Cl2 (1.0 mL) was stirred at room temperature for 18 hours. 
After being passed through a short silica gel column (eluent: hexane-EtOAc, 7:1→3:1), 
cycloadduct (1.59 g, 5.05 mmol), Pd(OAc)2 (11 mg, 0.05 mmol), triphenylphosphine (54 mg, 0.21 
mmol) and triethylamine (1.4 mL, 10.1 mmol) in 1,4-dioxane (10 mL) gave the crude product. 
Purification by flash column chromatography on silica gel (eluent: hexane-EtOAc, 14:1→7:1) gave 
dihydropyridazine 2c (1.06 g, 4.17 mmol, 82%) as a white solid; Rf (Hexane-EtOAc, 2:1) = 0.45; mp 
= 93-94 ˚C; 1H NMR (400 MHz, 298 K, d6-DMSO); δ 6.86-6.64 (br m, 2H, NC=H), 5.90-5.67 (br m, 
2H, NCHC=H), 4.89 (br sept, J = 6.1 Hz, 2H, OCH), 1.22 (br d, J = 6.1 Hz, 12H, CH3); 1H NMR (400 
MHz, 348 K, d6-DMSO); δ 6.74 (br dd, J = 5.2, 2.4 Hz, 2H, NC=H), 5.77 (br dd, J = 5.2, 2.4 Hz, 2H, 
NCHC=H), 4.91 (sept, J = 6.2 Hz, 2H, OCH), 1.25 (d, J = 6.2 Hz, 12H, CH3); 13C NMR (100 MHz, 298 
K, d6 -DMSO, additional peaks due to complex rate processes denoted by an asterisk); δ 152.6* 
(C=O), 151.9 (C=O), 127.4 (NC=H), 113.0* (NCHC=H), 111.7 (NCHC=H), 70.5 (OCH), 21.6 (CH3); 13C 
NMR (100 MHz, 348 K, d6-DMSO); δ 152.1 (C=O), 127.0 (NC=H), 111.8 (NCHC=H), 70.1 (OCH), 21.2 
(CH3); FTIR (ATR) ν (cm-1): 3090, 2986, 1748 (C=O), 1711 (C=O); HRMS (APCI): m/z calculated for: 
C12H18N2O4 [M+H]+ 255.1339, found 255.1329.  
 
Di-tert-butyl 1,2-dihydropyridazine-1,2-dicarboxylate (2d) 
Using general procedure B, di-tert-butyl azodicarboxylate (1.00 g, 4.35 mmol) and 1-acetoxy-1,3-
butadiene (0.8 mL, 6.53 mmol) in CH2Cl2 (1.7 mL) was stirred at 40 °C for 2 days. After the addition 
of hexane (20 mL), filtration and drying, cycloadduct (1.45 g, 4.23 mmol), Pd(OAc)2 (10 mg, 0.04 
mmol), triphenylphosphine (44 mg, 0.17 mmol) and triethylamine (1.2 mL, 8.5 mmol) in 1,4-
dioxane (8.5 mL) gave the crude product. Purification by flash column chromatography on silica 
gel (eluent: hexane-EtOAc, 19:1→9:1) gave dihydropyridazine 2d (912 mg, 3.23 mmol, 74%) as a 
white solid. Rf (Hexane-EtOAc, 1:1) = 0.64; mp = 94-95 ˚C; 1H NMR (400 MHz, 298 K, d6-DMSO); δ 
6.81-6.60 (br m, 2H, NC=H), 5.84-5.62 (br m, 2H, NCHC=H), 1.44 (s, 18H, CH3); 1H NMR (400 MHz, 
348 K, d6-DMSO); δ 6.69 (br dd, J = 5.3, 2.3 Hz, 2H, NC=H), 5.71 (br dd, J = 5.3, 2.3 Hz, 2H, NCHC=H), 
1.46 (s, 18H, CH3); 13C NMR (100 MHz, 298 K, d6 -DMSO, additional peaks due to complex rate 
processes denoted by an asterisk); δ 151.8* (C=O), 150.8 (C=O), 127.6 (NC=H), 111.9* (NCHC=H), 
111.6 (NCHC=H), 111.1* (NCHC=H), 81.9 (CO2C), 27.6 (CH3); 13C NMR (100 MHz, 348 K, d6-DMSO); 
δ 151.1 (C=O), 127.2 (NC=H), 111.3 (NCHC=H), 81.5 (CO2C), 27.4 (CH3); FTIR (ATR) ν (cm-1): 2974, 
1733 (C=O), 1718 (C=O); HRMS (ESI): m/z calculated for: C14H22N2O4 [M+Na]+ 305.1472, found 
305.1469.  
Scaled-up procedure: Using general procedure B, di-tert-butyl azodicarboxylate (5.01 g, 21.7 
mmol) and 1-acetoxy-1,3-butadiene (3.9 mL, 32.6 mmol) in CH2Cl2 (4.4 mL) was stirred at 40 °C 
for 2 days. After the addition of hexane (40 mL), filtration and drying, cycloadduct (6.90 g, 20.2 
mmol), Pd(OAc)2 (44 mg, 0.20 mmol), triphenylphosphine (216 mg, 0.82 mmol) and triethylamine 
(5.6 mL, 40.2 mmol) in 1,4-dioxane (40 mL) gave the crude product. Purification by flash column 
chromatography on silica gel (eluent: hexane-EtOAc, 19:1→14:1→9:1) gave dihydropyridazine 
2d (4.40 mg, 15.6 mmol, 72%) as a white solid (spectroscopic data identical to those given above). 
 
Dibenzyl-1,2-dihydropyridazine-1,2-dicarboxylate (2e) 
Using general procedure B, dibenzyl azodicarboxylate (1.24 g, 4.00 mmol) and 1-acetoxy-1,3-
butadiene (0.7 mL, 6.00 mmol) in CH2Cl2 (0.8 mL) was stirred at room temperature for 2 hours. 
After being passed through a short silica gel column (eluent: hexane-EtOAc, 7:1→3:1), 
cycloadduct (1.53 g, 3.72 mmol), Pd(OAc)2 (9 mg, 0.04 mmol), triphenylphosphine (42 mg, 0.16 
mmol) and triethylamine (1.1 mL, 7.89 mmol) in 1,4-dioxane (8 mL) gave the crude product. 
Purification by flash column chromatography on silica gel (eluent: hexane-EtOAc, 9:1→6:1) gave 
dihydropyridazine 2e (1.06 g, 3.02 mmol, 75%) as a highly viscous orange oil; Rf (Hexane-EtOAc, 
2:1) = 0.37; 1H NMR (400 MHz, 298 K, d6-DMSO); δ 7.43-7.29 (br m, 10H, ArCH), 6.90-6.75 (br m, 
2H, NC=H), 5.92-5.74 (br m, 2H, NCHC=H), 5.31-5.16 (br m, 4H, OCH2); 1H NMR (400 MHz, 348 K, 
d6-DMSO); δ 7.39-7.06 (br m, 10H, ArCH), 6.82 (dd, J = 5.2, 2.4 Hz, 2H, NC=H), 5.83 (dd, J = 5.2, 
2.4 Hz, 2H, NCHC=H), 5.26-5.19 (br m, 4H, OCH2); 13C NMR (100 MHz, 298 K, d6 -DMSO, additional 
peaks due to complex rate processes denoted by an asterisk); δ 153.2 (C=O), 152.4* (C=O), 135.6 
(ArC), 128.5 (ArCH), 128.2 (ArCH), 127.7 (ArCH or NC=H), 127.2 (ArCH or NC=H), 113.4* (NCHC=H), 
112.2 (NCHC=H), 67.8 (OCH2); 13C NMR (100 MHz, 348 K, d6-DMSO); δ 152.6 (C=O), 135.3 (ArC), 
128.0 (ArCH), 127.7 (ArCH), 127.2 (ArCH), 127.0 (NC=H), 112.3 (NCHC=H), 67.4 (OCH2); FTIR (ATR) 




Using general procedure C, a mixture of hydrazine S2 (1.02 g, 5.27 mmol), iodobenzene diacetate 
(1.78 g, 5.54 mmol) and 1-acetoxy-1,3-butadiene (0.9 mL, 7.89 mmol) in CH2Cl2 (5.3 mL) was 
stirred at 40 °C for 24 hours. After being passed through a short silica gel column (eluent: hexane-
EtOAc, 7:1→2:1), cycloadduct (1.47 g, 4.90 mmol), Pd(OAc)2 (24 mg, 0.11 mmol), 
triphenylphosphine (110 mg, 0.42 mmol) and triethylamine (1.5 mL, 10.5 mmol) in 1,4-dioxane 
(10.5 mL) gave the crude product. Purification by flash column chromatography on silica gel 
(eluent: hexane-EtOAc, 7:1→5:1) gave dihydropyridazine 2f (577 mg, 2.40 mmol, 46%) as an off-
white solid. Rf (Hexane-EtOAc, 2:1) = 0.37; mp = 70-72 ˚C; 1H NMR (400 MHz, 298 K, d6-DMSO); δ 
6.84-6.60 (br m, 2H, 2 x NC=H), 5.87-5.64 (br m, 2H, 2 x NCHC=H), 3.73 (br s, 3H, OCH3), 1.43 (br 
s, 9H, C-CH3); 1H NMR (400 MHz, 348 K, d6-DMSO); δ 6.74-6.70 (br m, 2H, 2 x NC=H), 5.78-5.72 
(br m, 2H, 2 x NCHC=H), 3.75 (s, 3H, OCH3), 1.45 (s, 9H, C-CH3); 13C NMR (100 MHz, 298 K, d6 -
DMSO, additional peaks due to complex rate processes denoted by an asterisk); δ 153.7 (C=O), 
152.8* (C=O), 151.8 (C=O), 127.8 (NC=H), 127.0 (NC=H), 113.0* (NCHC=H), 112.1 (NCHC=H), 
111.1 (NCHC=H), 82.3 (CO2C), 53.5 (OCH3), 27.6 (C-CH3); 13C NMR (100 MHz, 348 K, d6-DMSO); δ 
153.0 (C=O), 151.2 (C=O), 127.4 (NC=H), 126.8 (NC=H), 112.0 (NCHC=H), 111.4 (NCHC=H), 81.9 
(CO2C), 52.9 (OCH3), 27.4 (C-CH3); FTIR (ATR) ν (cm-1): 2984, 1748 (C=O), 1716 (C=O); HRMS (APCI): 
m/z calculated for: C11H16N2O4 [M-H]- 239.1037, found 239.1029.  
 
1-Benzyl-2-tert-butyl-1,2-dihydropyridazine-1,2-dicarboxylate (2g) 
Using general procedure C, a mixture of hydrazine S3 (1.01 g, 3.77 mmol), iodobenzene diacetate 
(1.27 g, 3.94 mmol) and 1-acetoxy-1,3-butadiene (0.67 mL, 5.63 mmol) in CH2Cl2 (1.5 mL) was 
stirred at room temperature for 17 hours. After being passed through a short silica gel column 
(eluent: hexane-EtOAc, 7:1→3:1), cycloadduct (1.23 g, 3.27 mmol), Pd(OAc)2 (15 mg, 0.07 mmol), 
triphenylphosphine (68 mg, 0.26 mmol) and triethylamine (0.9 mL, 6.54 mmol) in 1,4-dioxane 
(6.5 mL) gave the crude product. Purification by flash column chromatography on silica gel 
(eluent: hexane-EtOAc, 14:1→7:1) gave dihydropyridazine 2g (658 mg, 2.08 mmol, 55%) as highly 
viscous orange oil. Rf (Hexane-EtOAc, 2:1) = 0.45; 1H NMR (400 MHz, 298 K, d6-DMSO); δ 7.43-
7.27 (br m, 5H, ArCH), 6.86-6.68 (br m, 2H, 2 x NC=H), 5.89-5.67 (br m, 2H, 2 x NCHC=H), 5.37-
5.04 (br m, 2H, OCH2), 1.50-1.19 (br s, 9H, C-CH3); 1H NMR (400 MHz, 348 K, d6-DMSO); δ 7.40-
7.31 (br m, 5H, ArCH), 6.78-6.72 (m, 2H, 2 x NC=H), 5.81-5.73 (m, 2H, 2 x NCHC=H), 5.26-5.18 (m, 
2H, OCH2), 1.41 (s, 9H, C-CH3); 13C NMR (100 MHz, 298 K, d6-DMSO, additional peaks due to 
complex rate processes denoted by an asterisk); δ 153.2 (C=O), 152.3 (C=O), 135.7 (C10), 128.4 
(ArCH), 128.2 (ArCH), 127.8 (ArCH), 127.4 (NC=H), 126.9 (NC=H), 113.1* (NCHC=H), 112.3 
(NCHC=H), 111.2* (NCHC=H), 82.4 (CO2C), 67.5 (OCH2), 27.6 (C-CH3); 13C NMR (100 MHz, 348 K, 
d6-DMSO); δ 152.5 (C=O), 151.3 (C=O), 135.4 (ArC), 128.0 (ArCH), 127.7 (ArCH), 127.5 (NC=H), 
127.3 (ArCH), 126.7 (NC=H), 112.2 (NCHC=H), 111.5 (NCHC=H), 82.0 (CO2C), 67.2 (OCH2), 27.3 (C-
CH3); FTIR (ATR) ν (cm-1): 2978, 1713 (C=O); HRMS (ESI): m/z calculated for: C17H20N2O4 [M+Na]+ 
339.1315, found 339.1316.  
 
2-Phenyl-[1,2,4]triazolo[1,2-a]pyridazine-1,3-dione (2h)5 
Using general procedure C, a mixture of 4-phenyl urazole (1.03 g, 5.82 mmol), iodobenzene 
diacetate (1.88 g, 5.85 mmol) and 1-acetoxy-1,3-butadiene (1.0 mL, 8.46 mmol) in CH2Cl2 (10 mL) 
was stirred at room temperature for 1 hour. After the addition of hexane (20 mL), filtration and 
drying, cycloadduct (1.64 g, 5.69 mmol), Pd(OAc)2 (13 mg, 0.07 mmol), triphenylphosphine (60 
mg, 0.23 mmol) and triethylamine (1.6 mL, 11.4 mmol) in 1,4-dioxane (11 mL) gave the crude 
product. Purification by flash column chromatography on silica gel (eluent: hexane-EtOAc, 1:1) 
gave dihydropyridazine 2h (957 mg, 4.21 mmol, 72%) as a yellow solid. The spectroscopic data 
are consistent with those reported previously.4 1H NMR (400 MHz, CDCl3); δ 7.54-7.38 (br m, 5H, 
ArCH), 6.88 (br dd, J = 6.1, 2.7 Hz, 2H, NC=H), 5.34 (br dd, J = 6.1, 2.7 Hz, 2H, NCHC=H); 13C NMR 
(100 MHz, CDCl3); δ 142.7 (C=O), 131.0 (ArC), 129.4 (ArCH), 128.7 (ArCH), 125.8 (ArCH), 120.9 
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